Calcium antagonist reduces oxidative stress by upregulating Cu/Zn superoxide dismutase in stroke-prone spontaneously hypertensive rats

Hypertension Research

Volumn 27, Issue 11, 2004, Pages 877-885

  Umemoto, Seiji ^a   Tanaka, Masakazu ^b   Kawahara, Shinji ^b   Kubo, Makoto ^b   Umeji, Kyoto ^b   Hashimoto, Ryo ^b   Matsuzaki, Masunori ^b  

^a YAMAGUCHI UNIVERSITY HOSPITAL   (Japan)

^b YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Calcium antagonist; Hypertension; Oxidative stress; Superoxide dismutase

Indexed keywords

AMLODIPINE; CALCIUM ANTAGONIST; COPPER ZINC SUPEROXIDE DISMUTASE; ENALAPRIL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOWN REGULATION; DRUG POTENCY; ENZYME ACTIVITY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; HYPERTENSION; IMMUNOBLOTTING; LUMINESCENCE; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RANDOMIZATION; RAT; SPECTROPHOTOMETRY; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE; SYSTOLIC BLOOD PRESSURE; UPREGULATION;

AMLODIPINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CALCIUM CHANNEL BLOCKERS; CEREBROVASCULAR ACCIDENT; CORONARY VESSELS; ENALAPRIL; HYPERTENSION; MALE; MYOCARDIUM; NADPH OXIDASE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SUPEROXIDE DISMUTASE; UP-REGULATION;

EID: 14644433145     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.27.877     Document Type: Article

References (35)

1. Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M: Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 2000; 20: 2175-2183.
2. Zalba G, San Jose G, Moreno MU, et al: Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension 2001; 38: 1395-1399.
3. Vaziri ND, Lin CY, Farmand F, Sindhu RK: Superoxide dismutase, catalase, glutathione peroxidase and NADPH oxidase in lead-induced hypertension. Kidney Int 2003; 63: 186-194.
4. Fukai T, Folz RJ, Landmesser U, Harrison DG: Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc Res 2002; 55: 239-249.
5. Didion SP, Ryan MJ, Didion LA, Fegan PE, Sigmund CD, Faraci FM: Increased superoxide and vascular dysfunction in CuZnSOD-deficient mice. Circ Res 2002; 91: 938-944.
6. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M: Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci U S A 1991; 88: 10045-10048.
7. Kuwajima I, Kuramoto K, Ogihara T, et al: Tolerability and safety of a calcium channel blocker in comparison with a diuretic in the treatment of elderly patients with hypertension: secondary analysis of the NICS-EH. Hypertens Res 2001; 24: 475-480.
8. Yamamoto Y, Sonoyama K, Matsubara K, et al: The status of hypertension management in Japan in 2000. Hypertens Res 2002; 25: 717-725.
9. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288 2981-2997.
10. Pitt B, Byington RP, Furberg CD, et al: Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events: PREVENT Investigators. Circulation 2000; 102 1503-1510.
11. Mason RP: Mechanisms of plaque stabilization for the dihydropyridine calcium channel blocker amlodipine: review of the evidence. Atherosclerosis 2002; 165: 191-199.
12. Chen L, Haught WH, Yang B, Saldeen TG, Parathasarathy S, Mehta JL: Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine. J Am Coll Cardiol 1997; 30: 569-575.
13. Young AA, Legrice IJ, Young MA, Smaill BH: Extended confocal microscopy of myocardial laminae and collagen network. J Microsc 1998; 192(Pt 2): 139-150.
14. Kobayashi N, Mori Y, Nakano S, et al: TCV-116 stimulates eNOS and caveolin-1 expression and improves coronary microvascular remodeling in normotensive and angiotensin II-induced hypertensive rats. Atherosclerosis 2001; 158: 359-368.
15. Baba HA, Iwai T, Bauer M, Irlbeck M, Schmid KW, Zimmer HG: Differential effects of angiotensin II receptor blockade on pressure-induced left ventricular hypertrophy and fibrosis in rats. J Mol Cell Cardiol 1999; 31: 445-455.
16. Fujii K, Umemoto S, Fujii A, Yonezawa T, Sakumura T, Matsuzaki M: Angiotensin II type 1 receptor antagonist downregulates nonmuscle myosin heavy chains in spontaneously hypertensive rat aorta. Hypertension 1999; 33: 975-980.
17. Hermann M, Camici G, Fratton A, et al: Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension. Circulation 2003; 108: 2308-2311.
18. Shiomi T, Tsutsui H, Matsusaka H, et al: Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation 2004; 109: 544-549.
19. Nebot C, Moutet M, Huet P, Xu JZ, Yadan JC, Chaudiere J: Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol. Anal Biochem 1993; 214: 442-451.
20. Miller FJ Jr, Griendling KK: Functional evaluation of non-phagocytic NAD(P)H oxidases. Methods Enzymol 2002; 353: 220-233.
21. Chen X, Touyz RM, Park JB, Schiffrin EL: Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 2001; 38: 606-611.
22. Cai H, Griendling KK, Harrison DG: The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 2003; 24: 471-478.
23. Schwartzkopff B, Brehm M, Mundhenke M, Strauer BE: Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease. Hypertension 2000; 36: 220-225.
24. Vijayagopal P, Subramaniam P: Effect of calcium channel blockers on proteoglycan synthesis by vascular smooth muscle cells and low density lipoprotein - proteoglycan interaction. Atherosclerosis 2001; 157: 353-360.
25. Lai YM, Fukuda N, Su JZ, et al: Novel mechanisms of the antiproliferative effects of amlodipine in vascular smooth muscle cells from spontaneously hypertensive rats. Hypertens Res 2002; 25: 109-115.
26. Luoma JS, Stralin P, Marklund SL, Hiltunen TP, Sarkioja T, Yla-Herttuala S: Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler Thromb Vasc Biol 1998; 18: 157-167.
27. Park JB, Touyz RM, Chen X, Schiffrin EL: Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats. Am J Hypertens 2002; 15: 78-84.
28. Fukuo K, Yang J, Yasuda O, et al: Nifedipine indirectly upregulates superoxide dismutase expression in endothelial cells via vascular smooth muscle cell-dependent pathways. Circulation 2002; 106: 356-361.
29. Fukuo K, Yang J, Suzuki T, et al: Nifedipine upregulates manganese superoxide dismutase expression in vascular smooth muscle cells via endothelial cell-dependent pathways. Hypertens Res 2003; 26: 503-508.
30. Kerr S, Brosnan MJ, McIntyre M, Reid JL, Dominiczak AF, Hamilton CA: Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension 1999; 33: 1353-1358.
31. Cooke JP, Dzau VJ: Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 1997; 48: 489-509.
32. On YK, Kim CH, Oh BH, Lee MM, Park YB: Effects of angiotensin converting enzyme inhibitor and calcium antagonist on endothelial function in patients with essential hypertension. Hypertens Res 2002; 25: 365-371.
33. Csonka C, Pataki T, Kovacs P, et al: Effects of oxidative stress on the expression of antioxidative defense enzymes in spontaneously hypertensive rat hearts. Free Radic Biol Med 2000; 29: 612-619.
34. Marklund SL: Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem J 1984; 222: 649-655.
35. Chobanian AV, Bakris GL, Black HR, et al: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.